News
N.C. diagnostics firm LipoScience files for $86M IPO
MedCity News
June 24, 2011
LipoScience: LDL particle measurement by NMR recognized in consensus statement by the ADA and the ACC
Download the PDF
March 27, 2008
Significant Decision Gives Patients Better Access to LipoScience's Heart Disease Test
Download the PDF
December 2, 2005
LipoScience
Raleigh, NC
LipoScience is a diagnostic company utilizing nuclear magnetic resonance (NMR) spectroscopy to measure the size and quantity of lipoprotein particles in blood. The company's NMR LipoProfile® blood test is intended to provide a better indication of the risk of developing cardiovascular heart disease than the standard cholesterol test measurements of 'good' and 'bad' cholesterol. The company currently markets and sells the NMR LipoProfile test to physicians, other healthcare professionals, diagnostic laboratories and clinical research clients.